Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells
出版年份 2020 全文链接
标题
Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 7, Pages 1654
出版商
MDPI AG
发表日期
2020-04-10
DOI
10.3390/molecules25071654
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cytotoxic and multidrug resistance reversal activity of phenothiazine derivative is strongly enhanced by theobromine, a phytochemical from cocoa
- (2019) Kamila Środa-Pomianek et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Amyloid-beta Interactions with ABC Transporters and Resistance Modifiers
- (2018) JOSEPH MOLNAR et al. ANTICANCER RESEARCH
- Increased lipid peroxidation, apoptosis and selective cytotoxicity in colon cancer cell line LoVo and its doxorubicin-resistant subline LoVo/Dx in the presence of newly synthesized phenothiazine derivatives
- (2018) Kamila Środa-Pomianek et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo
- (2018) Anida Hasanovic et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran derivatives with telomeric DNA binding and antiproliferative activities
- (2018) Antonio Carella et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model
- (2015) Gerjo J. de Knegt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- Activity of the efflux pump inhibitor SILA 421 against drug-resistant tuberculosis
- (2013) Sami O. Simons et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421
- (2012) Ulrike Olszewski et al. Anti-Cancer Agents in Medicinal Chemistry
- The Hedgehog Receptor Patched Functions in Multidrug Transport and Chemotherapy Resistance
- (2012) M. Bidet et al. MOLECULAR CANCER RESEARCH
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
- (2010) L. D. Cripe et al. BLOOD
- A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
- (2010) R. J. Kelly et al. CLINICAL CANCER RESEARCH
- 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1
- (2010) Olga Wesołowska et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)
- (2009) Marta Martins et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges
- (2008) Suneet Shukla et al. Expert Opinion on Drug Metabolism & Toxicology
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now